For PD-L1, it was shown that its high serum content is an unfavorable prognostic factor in RCC and ovarian cancer (HR = 4.34; p = 0.0038 and HR = 2.36; p = 0.0168, respectively) (see Table 8 and Figure 4). Here, CD274 is linked to ovarian carcinoma.